Ivacaftor (VX-770)

Ivacaftor (VX-770, Kalydeco) is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

Catalog No.S1144
Price Stock Quantity  
USD 170 In stock
USD 320 In stock
USD 970 In stock
USD 2470 In stock

Free Overnight Delivery on all orders over $ 500.

Order now and get it on

Ivacaftor (VX-770) Chemical Structure

Ivacaftor (VX-770) Chemical Structure
Molecular Weight: 392.49

Validation & Quality Control

Quality Control & MSDS

Related Compound Libraries

Ivacaftor (VX-770) is available in the following compound libraries:

Product Information

  • Compare CFTR Chemicals
    Compare CFTR Chemicals
  • Research Area

Product Description

Biological Activity

Description Ivacaftor (VX-770, Kalydeco) is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.
Targets G551D-CFTR F508del-CFTR
IC50 100 nM 25 nM [1]
In vitro Ivacaftor (10 μM) significantly increases the forskolin-stimulated Cl- secretion (IT) by ~4-fold with an EC50 of 100 nM in the recombinant Fisher rat thyroid (FRT) cells expressing G551D gating mutation of CFTR, and by ~6-fold with an EC50 of 25 nM in the recombinant cells expressing temperature-corrected F508del processing mutation of CFTR. Consistent with the increases in the forskolin-stimulated IT, Ivacaftor (10 μM) increases the open probability (Po) of G551D-, F508del-, and wild-type CFTR by ~6-fold, ~5-fold and ~2-fold, respectively, indicating that Ivacaftor acts directly on CFTR to increase its gating activity. In primary cultured human CF bronchial epithelia (HBE) carrying the G551D and F508del CFTR mutations, Ivacaftor (10 μM) potently increases the forskolin-stimulated IT by ~10-fold from 5% to a maximum level of 48% of that measured in non-CF HBE, with an EC50 of 236 nM displaying ~70-fold more potency compared with the commonly used CFTR potentiator genistein, which has an EC50 of 16 μM. In HBE with F508del homozygous CFTR, Ivacaftor causes a significant increase in the forskolin-stimulated IT with an EC50 of 22 nM, to a less extent from 4% to 16% of non-CF HBE compared with the effect in G551D/F508del HBE. Due to CFTR potentiation, Ivacaftor inhibits excessive ENaC-mediated Na+ and fluid absorption with an IC50 of 43 nM, and decreases the amiloride response, resulting in an increase in the surface fluid and cilia beat frequency (CBF) in G551D/F508del HBE. [1]
In vivo
Clinical Trials A Phase III study of Ivacaftor in cystic fibrosis subjects age 6 to 11 with the G551D mutation has been completed.
Features Ivacaftor is the first potent and orally available CFTR potentiator to enter human clinical trials.

Protocol(Only for Reference)

Kinase Assay: [1]

Ussing Chamber Recordings The effect of Ivacaftor on CFTR-mediated Cl- secretion is characterized by measuring the CFTR-mediated IT in chambers using recombinant Fisher rat thyroid (FRT) cells expressing G551D, or F508del CFTR. Cells are grown on Costar Snapwell cell culture inserts maintained at 37 °C before recording. The cell culture inserts are mounted into an Ussing chamber to record IT in the voltage-clamp mode (Vhold = 0 mV). For FRT cells, the basolateral membrane is permeabilized with 360 μg/mL Nystatin and a basolateral to apical Cl- gradient is established. The basolateral bath solution contains 135 mM NaCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 2.4 mM K2HPO4, 0.6 mM KHPO4, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes), and 10 mM dextrose (titrated to pH 7.4 with NaOH). The apical NaCl is replaced by equimolar Na+ gluconate (titrated to pH 7.4 with NaOH). The addition of a maximally effective concentration of forskolin (10 μM) is used to stimulate IT in the presence of various concentrations of Ivacaftor. All recordings are digitally acquired using Acquire and Analyze software. EC50 values are determined from the concentration-response curve of the increase in forskolin-stimulated IT after application of Ivacaftor.
1

References

Chemical Information

Download Ivacaftor (VX-770) SDF
Molecular Weight (MW) 392.49
Formula

C24H28N2O3

CAS No. 873054-44-5
Synonyms N/A
Solubility (25°C)
  • DMSO 79 mg/mL
  • Water <1 mg/mL
  • Ethanol <1 mg/mL
Storage 2 years -20°CPowder
2 weeks4°Cin DMSO
6 months-80°Cin DMSO
Chemical Name N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

Research Area

Product Citations (1)

  • A young Hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: is ivacaftor an option for therapy? [Yarlagadda S, et al. Am J Respir Crit Care Med 2012;186(7), 694-696]

    PubMed: 23027855

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3Monday–Friday 9:00 AM–5:00 PM (Central Time)

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related CFTR Chemicals

  • VX-809

    VX-809 is a CFTR modulator with EC50 of 0.1 μM.

  • PTC124 (Ataluren)

    PTC124 (Ataluren) is a potent nonsense mutation inhibitor with EC50 of ~0.1 μM.

  • VX-661

    VX-661 is a second F508del CFTR corrector and is believed to help CFTR protein reach the cell surface.

  • TRAM-34

    TRAM-34 is a selective and potent inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1) with Kd of 20 nM.

  • Oligomycin A

    Oligomycin A is a specific inhibitor of complex V (ATP synthase) of the electron transport chain.

  • LY335979 (Zosuquidar 3HCl)

    LY335979 (Zosuquidar) is a potent modulator of P-glycoprotein-mediated multidrug resistance with Ki of 60 nM.

  • PF 3716556

    PF 3716556 is a potent, and selective acid pump antagonist with pIC50 of 6.026, 6.038 and 6.009 at pH 6.4 for the inhibition of H+/K+-ATPase activity of porcine, canine and human ion-leaky membrane vesicles, respectively.

  • Manidipine 2HCl (CV-4093)

    Manidipine HCl is a HCl salt form of Manidipine which is a calcium channel blocker for Ca2+ current with IC50 of 2.6 nM.

  • Omecamtiv mecarbil (CK-1827452)

    Omecamtiv mecarbil (CK-1827452) is a specific cardiac myosin activator and a clinical drug for left ventricular systolic heart failure.

  • A-803467

    A-803467 is a selective NaV1.8 channel blocker with IC50 of 8 nM.

Recently Viewed Items

Tags: buy Ivacaftor (VX-770) | Ivacaftor (VX-770) ic50 | Ivacaftor (VX-770) price | Ivacaftor (VX-770) cost | Ivacaftor (VX-770) solubility dmso | Ivacaftor (VX-770) purchase | Ivacaftor (VX-770) manufacturer | Ivacaftor (VX-770) research buy | Ivacaftor (VX-770) order | Ivacaftor (VX-770) mouse | Ivacaftor (VX-770) chemical structure | Ivacaftor (VX-770) mw | Ivacaftor (VX-770) molecular weight | Ivacaftor (VX-770) datasheet | Ivacaftor (VX-770) supplier | Ivacaftor (VX-770) in vitro | Ivacaftor (VX-770) cell line | Ivacaftor (VX-770) concentration | Ivacaftor (VX-770) nmr
Contact Us